Skip to content

Thuisverpleging De Kolibrie: what changed

BE 1010.917.865NACE 86.940, Nursing and midwiferyOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€32,675
2024 · €10,550+€22,125
Equity
€45,225
2024 · €12,550+€32,675
Cash
€44,824
2024 · €14,393+€30,431
Balance sheet total
€52,048
2024 · €20,834+€31,214

Largest movements

2024 to 2025
Assets
  • Cash +€30,431

    up €30,431 (+211%), from €14,393 to €44,824

    mainly Net result for the year (+€32,675)

Equity and liabilities
  • Reserves +€32,675

    up €32,675 (+310%), from €10,550 to €43,225

  • Other debts -€1,281

    down €1,281 (-39.3%), from €3,257 to €1,976

Income statement
  • Gross operating margin +€28,084

    up €28,084 (+206%), from €13,603 to €41,686

  • Taxes +€5,864

    up €5,864 (+197%), from €2,976 to €8,840

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €10,550
Gross operating margin +€28,084
Other operating charges -€120
Financial income +€3
Financial charges +€23
Taxes -€5,864
Result 2025 €32,675
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€30,431
Investment €0
Financing €0
Cash 2024 €14,393
Net result for the year +€32,675
Receivables within one year -€410
Deferred charges and accrued income -€373
Trade debts -€180
Other debts -€1,281
Cash 2025 €44,824
brings cash intakes cash out
Every line side by side 30 lines
Line Code 2024 2025 Change %
Total assets 20/58 €20,834 €52,048 +€31,214 +150%
Current assets 29/58 €20,834 €52,048 +€31,214 +150%
Amounts receivable within one year 40/41 €6,350 €6,760 +€410 +6.5%
Trade receivables 40 €6,350 €5,600 -€750 -11.8%
Other amounts receivable 41 - €1,160 +€1,160
Cash at bank and in hand 54/58 €14,393 €44,824 +€30,431 +211%
Deferred charges and accrued income 490/1 €91 €465 +€373 +408%
Total equity and liabilities 10/49 €20,834 €52,048 +€31,214 +150%
Equity 10/15 €12,550 €45,225 +€32,675 +260%
Contributions 10/11 €2,000 €2,000 = 0.0%
Reserves 13 €10,550 €43,225 +€32,675 +310%
Distributable reserves 133 €10,550 €43,225 +€32,675 +310%
Amounts payable 17/49 €8,284 €6,824 -€1,461 -17.6%
Amounts payable within one year 42/48 €8,284 €6,824 -€1,461 -17.6%
Trade debts 44 €552 €372 -€180 -32.6%
Suppliers 440/4 €552 €372 -€180 -32.6%
Taxes, remuneration and social security 45 €4,476 €4,476 = 0.0%
Taxes 450/3 €4,476 €4,476 = 0.0%
Other amounts payable 47/48 €3,257 €1,976 -€1,281 -39.3%
Other operating charges 640/8 - €120 +€120
Gross operating margin 9900 €13,603 €41,686 +€28,084 +206%
Operating profit (loss) 9901 €13,603 €41,566 +€27,964 +206%
Financial income 75/76B - €3 +€3
Recurring financial income 75 - €3 +€3
Financial charges 65/66B €77 €54 -€23 -29.9%
Recurring financial charges 65 €77 €54 -€23 -29.9%
Profit (loss) for the period before taxes 9903 €13,526 €41,515 +€27,989 +207%
Income taxes 67/77 €2,976 €8,840 +€5,864 +197%
Profit (loss) for the period 9904 €10,550 €32,675 +€22,125 +210%
Profit (loss) for the period to be appropriated 9905 €10,550 €32,675 +€22,125 +210%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€99,798 to €130,672

Midpoint €112,662 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €45,225
Capitalised earnings €154,371 to €216,120
Indication €99,798 to €130,672

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€45,225
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€45,225

Capitalised earnings

net result for the year (9904)
2025
€32,675
2024
€10,550
Average result
€21,612
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€154,371 / €180,100 / €216,120

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.